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Bacterial corneal ulcer associated with
common variable immune deficiency
Edmund Tsui1,2 , Jie Deng3, Andrew N Siedlecki3 and Michael E Zegans3,4*
Abstract
Common variable immune deficiency (CVID) is one of the most commonly diagnosed primary immunodeficiencies.
Generally, patients have a history of recurrent sinopulmonary infections, hypogammaglobulinemia of two or more
immunoglobulin isotypes, and impaired functional antibody responses. Reports of corneal involvement associated
with CVID are limited. We describe a case of corneal ulceration associated with methicillin-resistant Staphylococcus
aureus in a patient with CVID that developed while on monthly intravenous immunoglobulin infusions and in
which there were no common risk factors for bacterial keratitis, such as prior history of ocular surface disease,
trichiasis, trauma, or contact lens wear.
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Introduction
Common variable immune deficiency (CVID) is the
most commonly encountered symptomatic primary im-
munodeficiency [1]. Herein, we describe an unusual
presentation of a corneal ulcer in a patient with a history
of CVID.
Case report
An 82-year-old female who was routinely followed for bi-
lateral dry age-related macular degeneration (AMD) was
noted to have corneal thinning in her left eye and referred
to the cornea service for further evaluation. The patient
had a history of hypogammaglobulinemia diagnosed ap-
proximately 8.5 years prior to presentation with a docu-
mented history of low immunoglobulin levels, specifically
an IgG of 61 mg/dL, IgA < 16 mg/dL, and IgM < 5 mg/dL.
At that time, she began monthly intravenous immuno-
globulin (IVIG) infusions. Past ocular history was pertin-
ent for bilateral cataract extraction with intraocular lens
implant 15 years prior to presentation and dry AMD bilat-
erally. There was no history of ocular trauma, lagophthal-
mos, or contact lens wear. She had a history of recurrent
sinus infections since her teenage years. Additionally, she
had a history of oral and esophageal lichen planus treated
with oral cyclosporine, recurrent urinary tract infections,
microscopic colitis, diabetes mellitus, and hypertension.
On initial presentation, she complained of irritation of the
left eye for 2 weeks. The visual acuity was 20/20 in her
right eye at distance, and her left eye was 8/200e at dis-
tance and 20/800 at near. There was no afferent pupillary
defect in her right eye, but her left eye was unable to be
assessed due to significant corneal opacities. Intraocular
pressures were 10 mmHg in the right eye and 9 mmHg in
the left eye. On slit lamp exam of her left eye, there were
dilated iris vessels in all quadrants and a 1.0 mm× 1.0 mm
(1.00 mm2) area of minimal thinning of the central cornea
with intact epithelium without staining or infiltrate.
Funduscopic exam was unchanged from prior examina-
tions, demonstrating extensive macular pigment atrophy
bilaterally without hemorrhage. Given the sterile appear-
ance, she was started on Tobradex (tobramycin/dexa-
methasone) ophthalmic ointment four times daily. She
was evaluated by the retina service 6 days after initial pres-
entation with an unchanged funduscopic exam without
evidence of ocular ischemia and a stable corneal exam.
Upon follow-up 2 weeks after initial presentation, her
visual acuity in her left eye was 4/200e at distance and 20/
800 at near, there was 2+ conjunctival injection, there
were dilated iris vessels, and her left cornea had a central
1.5-mm area of 90 % thinning with epithelial defect but
still no infiltrate. Tobradex was stopped, she was started
on doxycycline 100 mg twice daily and Vigamox four
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times daily, and corneal cultures were obtained. Clinical
labs were negative, including c-ANCA, p-ANCA, ANA,
myeloperoxidase antibody, PR-3 antibody, syphilis IgG,
and rheumatoid factor level of 10 units. Cultures from her
left cornea grew methicillin-resistant Staphylococcus aureus
(MRSA) within 48 h. Vancomycin 25 mg/cc drops was
added every 2 h, and oral doxycycline and Vigamox were
continued. She was seen regularly for follow-up with even-
tual healing of her epithelial defect over the following
month. Two months after initial presentation, she devel-
oped an acute conjunctivitis in her left eye. Conjunctival
cultures were obtained, and she was started empirically on
ciprofloxacin ophthalmic ointment four times daily. Con-
junctival cultures eventually grew MRSA, so vancomycin
25 mg/cc drops four times daily and oral doxycycline
100 mg twice daily were restarted, and she continued her
topical ciprofloxacin ophthalmic ointment four times daily.
At follow-up 2.5 months after initial presentation, her con-
junctivitis had resolved and corneal thinning had been
stable at 70–80 % thinning, but iris vessels of the left eye
remained significantly dilated. She was started on Tobradex
ophthalmic ointment twice daily (given that her prior
MRSA cultures were gentamicin sensitive and to reduce
the inflammation likely driving her persistently dilated left
eye iris vessels) and continued her oral doxycycline 100 mg
twice daily. Four months after initial presentation, her left
cornea had a central 2.0-mm area of 80 % corneal thinning
and scarring but with no infiltrate or epithelial defect and a
left eye visual acuity at 20/400. At her most recent appoint-
ment, 8 months after the ulcer was initially noted, her left
eye visual acuity was 20/400 and her left cornea had a cen-
tral 2.0-mm area of 80 % corneal thinning with irregular-
ities of the epithelium but no epithelial infiltrates or defect.
She remains on artificial tears four times daily. Her vision
in her left eye remains limited by her AMD, with visual
acuity prior to the episode of corneal ulcer ranging from
20/400 to 20/800.
Discussion
CVID is characterized by recurrent sinopulmonary infec-
tions, decreased levels of immunoglobulin, and impaired
functional antibody responses. The prevalence of CVID is
reported to range from one in 50,000 to one in 200,000
[1]. Patients with CVID present with a bimodal age distri-
bution with the majority diagnosed either in childhood or
in their second or third decade of life, although some
patients present later in their adult life [1]. Autoimmune
diseases, including lichen planus [2], are also seen in
approximately 25 % of patients with CVID [1].
Cases of corneal disease in patients with CVID are
limited in the literature. These studies suggest that kera-
titis in CVID may manifest as infectious and/or inflam-
matory in nature [3, 4]. Bilateral consecutive sterile
corneal thinning that progressed to perforations was
reported in a patient with CVID by Akpek et al. [3]. In
this case, multiple scrapings, biopsies, and cultures
remained sterile and the corneal infiltrates showed no
response to antibiotics but disappeared with topical ster-
oid therapy. It was postulated that the corneal perfora-
tions may have initially been due to an autoimmune
etiology and then complicated by a secondary Haemoph-
ilus influenzae endophthalmitis. Though we eventually
isolated MRSA from the cornea of our patient, her initial
presentation appeared more consistent with a sterile
melt (intact epithelium and no infiltrate) and she did not
have the typical risk factors for infectious keratitis such
as trauma, contact lens wear, or lagophthalmos. Our
eventual recovery of MRSA from her cornea and later
from her conjunctiva suggests that it is prudent to main-
tain a high level of suspicion for an infectious etiology in
patients with ocular surface disease and CVID even if
their initial presentation does not appear to be typical of
an infection.
Reports of other ocular manifestations in CVID are
also limited and include retinal vasculitis [4], uveitis [4],
keratoconjunctivitis [5, 6], and episodic retinal vein
occlusions [7]. In several of these cases, initiation of
treatment of IVIG and/or steroids led to the resolution
of uveitis or granulomatous lesions [4, 5] and recurrent
keratoconjunctivitis [5]. Patients that have CVID may re-
quire lifelong immunoglobulin replacement to prevent
further ocular and systemic manifestations of disease.
Corneal cultures may be indicated to evaluate for an in-
fectious etiology, such as in the case presented above. It
may be prudent to start patients on empiric topical anti-
biotics and steroids, given the devastating sequelae seen
in the case by Akpek et al. [3].
Common organisms isolated from ocular infections in
patients with CVID are S. aureus and encapsulated bac-
teria, such as Streptococcus pneumoniae and H. influen-
zae. Ocular infections with these organisms primarily
involve the conjunctiva and secondarily involve the cor-
nea. A study by Franklin et al. included five patients with
CVID over 2 years. Conjunctival cultures from three pa-
tients grew H. influenzae, one culture grew Staphylococ-
cus epidermidis, and one grew S. aureus [8]. Similarly, a
patient with multi-organism keratoconjunctivitis de-
scribed by Ooi et al. had conjunctival cultures that grew
H. influenzae and S. aureus [5]. The patient in the case
reported by Akpek et al. eventually developed a second-
ary endophthalmitis due to H. influenzae [3].
Systemic administration of IVIG is the primary treat-
ment for many forms of hypogammaglobulinemia, in-
cluding CVID. However, it has been demonstrated that
even in immunocompetent individuals, levels of immu-
noglobulins in the tear film do not reflect those in the
serum suggesting autonomous local regulation of im-
munoglobulin [9]. Indeed, it has been established that
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ocular immunoglobulins are produced locally by both
the lacrimal gland and the eye-associated lymphoid tis-
sue in the conjunctiva [10]. Further, IVIG only includes
IgG and not other isotypes, such as IgA, the primary im-
munoglobulin responsible for mucosal defense. Al-
though tear film immunoglobulin levels in patients with
CVID have not been studied, it can be conjectured that
tear film immunoglobulins are also decreased. Therefore,
mucosal defense at the ocular surface could remain sus-
ceptible despite systemic IVIG treatment. Further com-
plicating diagnosis and treatment is the fact that while
CVID is a form of immunosuppression, it is also associ-
ated with autoimmune disease. As noted above, our pa-
tient had lichen planus for which she was receiving oral
cyclosporine adding to her impaired immune response
to corneal infection. We postulate that the combination
of CVID and treatment with cyclosporine account for
the development and atypical presentation of bacterial
keratitis in this patient.
In conclusion, patients with CVID on monthly IVIG
infusions may still develop infectious diseases of the
ocular surface without the typical findings of bacterial
infection. Investigation for an infectious etiology should
be performed and treatment promptly implemented
when presented with conjunctival or corneal inflamma-
tion or ulceration.
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